ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MOL Moleculin Biotech Inc

0.00
0.00 (0.00%)
- - Closed
Realtime Data
Share Name Share Symbol Market Type
Moleculin Biotech Inc TG:MOL Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

MOL Management Overhaul Not Aimed To Lay Off Staff

24/07/2012 10:33am

Dow Jones News


Moleculin Biotech (TG:MOL)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Moleculin Biotech Charts.

By Veronika Gulyas

BUDAPEST--An ongoing management overhaul at refiner MOL Nyrt. (MOL.BU), Hungary's largest company by revenue, isn't aimed at cutting head count, the company's spokesman told Dow Jones Newswires Tuesday.

"The aim is not to lay off staff," Domokos Szollar said, "but to adjust to the firm's growing international presence."

The company is to set up a 500-strong international management base in Hungary's capital, Budapest, separating Hungarian and international operations. The firm launched an international recruitment campaign Tuesday to find the most eligible staff for this center, Mr. Szollar added.

The company also plans to give more freedom to the management of local flagship arms, Croatia's INA d.d.(IINFJ), Italy's Italiana Energia e Servizi and Slovakia's Slovnaft a.s. (1SLN01AE.BS), the spokesman said.

The changes aren't expected to cost much and savings are as yet unknown. The number of employees cannot change during the overhaul--effective as of Oct. 1, Mr. Szollar said.

MOL generated net profit of 73.7 billion Hungarian forints ($321.1 million) in the first quarter 2012, down 20% compared to the same period of the previous year.

MOL traded up 0.7% or HUF110 at HUF16,550 at 0847 GMT.

Write to Veronika Gulyas at veronika.gulyas@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Moleculin Biotech Chart

1 Year Moleculin Biotech Chart

1 Month Moleculin Biotech Chart

1 Month Moleculin Biotech Chart

Your Recent History

Delayed Upgrade Clock